DONATE

Núria Montserrat in a feature article at the ERC’s covid-19 section: Stopping coronavirus at the gate

ERC grantee Nuria Montserrat and her team create tiny kidneys which are proving to be key in the search for coronavirus drugs. The researcher is working with other international researchers and found that a trial drug could block early stages of COVID19. The ERC has created a section which is updated with the latest news about the ERC-funded research in coronavirus.

Samuel Sánchez wins an ERC Consolidator Grant to study the collective behaviour of self-propelled nanorobots


Samuel Sánchez, Group Leader at IBEC and ICREA Research Professor, has been awarded the prestigious “Consolidator Grant” of the European Research Council (ERC). With his i-NANOSWARMS project, Sánchez and his team at the Smart Nano-Bio-Devices Group will study the collective behaviour of nanorobots capable of self-propelling, and thus study their possible application in drug delivery and imaging diagnosis.

The highly sought-after ERC Consolidator grants are awarded to EU-based principal investigators with at least seven and up to twelve years of experience after his PhD who have demonstrated talent and scientific potential.

Núria Montserrat represents the european research council at the world economic forum in China

The researcher Núria Montserrat accompanies the president of the European Research Council (ERC) together with a selection of the best European researchers, at the Summer Davos annual Meeting, organised by the World Economic Forum (WEF). She has participated in several forums about how to work on more prosperous future and she explained how the research in organ regeneration that she is currently undertaking at IBEC can help in the fight against cancer.

The Annual Meeting of the New Champions (AMNC) also known as Summer Davos, is one of the events that brings together the brightest minds on the planet to discuss issues related to scientific research, leadership, and innovation. On this occasion, the forum was from 1 to 3 July and was held in the Chinese city of Dailan with the participation of the European delegation composed of its president, the mathematician Jean-Pierre Bourguignon and ten of the most outstanding European scientists.

IBEC’S Nano Robots presented at the European Research Council

Research Professor Samuel Sánchez presented last March 3rd in Brussels the new generation of NanoBots and BioBots developed in his research group at Institute of Bioengineering of Catalonia (IBEC) in Barcelona.

The presentation took place during the European Research Council (ERC) Seminars. The audience was composed of scientific personnel of ERC, as well as a general audience from the European Commission.
With the title “Nanobots to 3D BioBots as future tools in robotics and medicine” Professor Sánchez presented during his seminar, fundamental aspects of catalytically powered nanoparticles -also called nanobots-, their applications in environmental remediation and also in future smart nanomedicine.

ERC President visits IBEC

The President of the European Research Council, Jean-Pierre Bourguignon, visited last May 15th the Institute for Bioengineering of Catalonia (IBEC).

The event was inaugurated by IBEC’s Director, Josep Samitier, who presented an overview on the cutting-edge research carried out at the institute in the fields of bioengineering and nanomedicine.

Afterwards, ERC Grantees working at IBEC had the opportunity to explain the impact of ERC grants on their professional careers and established a dialogue with ERC President on the past, present and future of the European Research Council.

ERC funding for new diabetes approach at IBEC

javierramon2_tiIBEC’s Dr. Javier Ramón is one of just six researchers in Catalonia to have been awarded a 2016 Starting Grant by the European Research Council (ERC).

The senior researcher in the Biomimetic Systems for Cell Engineering group won funding for his project ‘Diabetes Approach by Multi-Organ-on-a-Chip’ (DAMOC) from Europe’s most prestigious funding body.

With the support, which will last for up to five years, Javier will start a new line to design a innovative new tool to test drugs for diabetes. As well as improving drug testing approaches, the multi-organ-on-a-chip device will provide new therapies to prevent the loss of beta cell mass and defects in the glucose uptake in skeletal muscle associated with type 2 diabetes.

“This project will give me the opportunity to have a multidisciplinary group of researchers working together from the beginning in a synchronized way, the most rewarding experience that a researcher can have,” he says.